Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F20VM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,154
Award facts
- Contract value 100% obligated
- $57,154.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $57,154.49 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). The contract, structured as a firm fixed-price delivery order with no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. This delivery order operates under AmerisourceBergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (operating under the AmerisourceBergen trade name), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's parent organization, Cencora, Inc., holds the primary IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, which enables the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Gemtesa, a prescription medication used in the treatment of overactive bladder, represents one of numerous pharmaceutical commodities delivered through this federal supply relationship.
Quick answers
Who was awarded contract SPE2DR26F20VM?
SPE2DR26F20VM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F20VM worth?
The government has obligated $57,154 on SPE2DR26F20VM.
Is contract SPE2DR26F20VM an order under another contract?
Yes. SPE2DR26F20VM is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20VM competed?
The extent of competition for SPE2DR26F20VM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award